Evidence map›Paper›PMID 33918987›Full record

ArticlePharmaceuticals (Basel, Switzerland)2021

Standardization of the [

Leonardo L Fuscaldi, Danielle V Sobral, Ana Claudia R Durante, Fernanda F Mendonça, Ana Cláudia C Miranda, Marcelo L da Cunha, Luciana Malavolta, Jorge Mejia, Marycel F de Barboza

Open access · goldAbstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 30 citations in OpenAlex.

  1. The novel [RSC advances · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Pharmaceutics · 2025
    Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Good practices forEJNMMI radiopharmacy and chemistry · 2022
    Review
  15. Quality control of [EJNMMI radiopharmacy and chemistry · 2022
    Article
  16. Article
  17. Article
  18. Bio-Evaluation ofFrontiers in medicine · 2022
    Article
  19. Article
  20. Time-efficient HPLC Validation Methodology for the Qualitative Analysis of 68Ga PSMA-11 in Routine Clinical Usage under Isocratic Method.Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Leonardo L FuscaldiHospital Israelita Albert Einstein, Sao Paulo 05652-900, Brazil.ORCID 0000-0001-7864-1324
Danielle V SobralDepartment of Physiological Sciences, School of Medical Sciences, Santa Casa de Sao Paulo, Sao Paulo 01221-020, Brazil.
Ana Claudia R DuranteHospital Israelita Albert Einstein, Sao Paulo 05652-900, Brazil.ORCID 0000-0002-6400-3986
Fernanda F MendonçaDepartment of Physiological Sciences, School of Medical Sciences, Santa Casa de Sao Paulo, Sao Paulo 01221-020, Brazil.
Ana Cláudia C MirandaHospital Israelita Albert Einstein, Sao Paulo 05652-900, Brazil.ORCID 0000-0002-0232-5138
Marcelo L da CunhaHospital Israelita Albert Einstein, Sao Paulo 05652-900, Brazil.
Luciana MalavoltaDepartment of Physiological Sciences, School of Medical Sciences, Santa Casa de Sao Paulo, Sao Paulo 01221-020, Brazil.ORCID 0000-0002-5199-5760
Jorge MejiaHospital Israelita Albert Einstein, Sao Paulo 05652-900, Brazil.ORCID 0000-0002-1182-4668
Marycel F de BarbozaHospital Israelita Albert Einstein, Sao Paulo 05652-900, Brazil.
Hospital Israelita Albert Einstein · BRFaculdade de Ciências Médicas da Santa Casa de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prostate-specific membrane antigen (PSMA) is a glycoprotein present in the prostate, that is overexpressed in prostate cancer (PCa). Recently, PSMA-directed radiopharmaceuticals have been developed, allowing the pinpointing of tumors with the Positron Emission Tomography (PET) or Single Photon Emission Computed Tomography (SPECT) imaging techniques. The aim of the present work was to standardize and validate an automatic synthesis module-based radiolabeling protocol for [

Indexed as

automatic synthesis modulegallium-68PET imagingprostate cancerPSMA-11

Identifiers

PMID33918987
PMCPMC8142994
OpenAlexW3154298706

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.